Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KOPRAN. Gains 5%; BSE HEALTHCARE Index Down 0.2%
Thu, 17 Oct 9:54

KOPRAN. Gains 5%; BSE HEALTHCARE Index Down 0.2%Image source: Kameleon007 /www.istockphoto.com

KOPRAN. share price has zoomed 5% and is presently trading at Rs 313.9.

Meanwhile, the BSE HEALTHCARE index is at 44,564.6 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 2.2%) and GSK Pharma (up 2.1%).

Torrent Pharma (down 1.7%) and Jubilant Pharmova (down 1.3%) are among the top losers today.

Over the last one year, KOPRAN. has moved up from Rs 224.0 to Rs 313.9, registering a gain of Rs 89.9 (up 40.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,166.2 to 44,564.6, registering a gain of 58.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 198.8%), Glenmark Pharma (up 122.4%) and SUVEN PHARMACEUTICALS (up 114.3%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,205.7 (down 0.4%).

The top losers among the BSE Sensex today are M&M (down 2.5%) and Maruti Suzuki (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,821.7 (down 0.6%). Bajaj Auto and Hero Motocorp are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,166.9 to 81,205.7, registering a gain of 15,038.7 points (up 22.7%).

KOPRAN. Financial Update...

KOPRAN. net profit grew 300.1% YoY to Rs 111 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 19.2% to Rs 1,394 million during the period as against Rs 1,170 million in April-June 2023.

For the year ended March 2024, KOPRAN. reported 87.1% increase in net profit to Rs 510 million compared to net profit of Rs 272 million during FY23. Revenue of the company grew 11.5% to Rs 6,146 million during FY24.

The current Price to earnings ratio of KOPRAN., based on rolling 12 month earnings, stands at 25.5.


Equitymaster requests your view! Post a comment on "KOPRAN. Gains 5%; BSE HEALTHCARE Index Down 0.2%". Click here!